Q2 2025 Lifeward Ltd Earnings Call Transcript
Key Points
- Lifeward Ltd (LFWD) achieved FDA clearance for the ReWalk 7 personal Exoskeleton, marking a significant innovation in their product line.
- The company reported a record quarter for Real Medicare placements, indicating strong market adoption.
- Transition to in-house manufacturing of the ReWalk personal Exoskeleton has led to cost savings, improved quality control, and greater production flexibility.
- Lifeward Ltd (LFWD) has expanded its payer base in the US, enhancing its lead pipeline and processing timelines for workers' compensation claims.
- The company improved its quarterly cash flow to $3.9 million, down from $5.6 million in Q2 2024, driven by operational efficiencies and facility consolidations.
- Revenue for Q2 2025 decreased by $1 million or about 15% compared to the second quarter of 2024.
- GAAP operating expenses increased to $9.1 million in Q2 2025 from $7.2 million in Q2 2024, largely due to a $2.8 million goodwill impairment charge.
- Medicare collections remain slower than anticipated, affecting cash flow and operational efficiency.
- Inventory levels increased due to the transition to in-house manufacturing and the need to support production for both ReWalk 6 and ReWalk 7.
- The company adjusted its full 2025 guidance, reflecting a more cautious outlook on revenue and non-GAAP net loss.
Good day and welcome to the second quarter 2025 Lifeward conference call.
(Operator Instructions)
I would now like to turn the conference over to Mr. Almog Adar, please go ahead.
Thank you, Alicia. Good morning and welcome to Lifeward's second quarter 2025 earnings call. I am Almog Adar, Lifeward's Chief Financial Officer, and with me on today's call is Mark Grant, our President and Chief Executive Officer.
Earlier this morning, Lifeward issued a press release detailing financial results for the three and six months ended June 30, 2025. The press release and webcast of this call can be accessed through the investor relations section of the Lifeward website at golifeward.com.
Before we get started, I would like to remind everyone. That any statement made on today's conference call that expressed a belief expectation, projection, forecasts, anticipation, or intent regarding future events and the company's future performance may be considered forward-looking statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
